OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances of redox-responsive nanoplatforms for tumor theranostics
Miaomiao Chen, Dapeng Liu, Fusheng Liu, et al.
Journal of Controlled Release (2021) Vol. 332, pp. 269-284
Closed Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
Zhilin Li, Xiaoqin Lai, Shiqin Fu, et al.
Advanced Science (2022) Vol. 9, Iss. 22
Open Access | Times Cited: 378

Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Jin Zhang, Yandai Lin, Zhe Lin, et al.
Advanced Science (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 190

Tumor‐Microenvironment‐Responsive Cascade Reactions by a Cobalt‐Single‐Atom Nanozyme for Synergistic Nanocatalytic Chemotherapy
Shuangfei Cai, Jiaming Liu, Jianwei Ding, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 48
Closed Access | Times Cited: 172

Current research trends of nanomedicines
Qiuyue Liu, Jiahui Zou, Zhongjian Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4391-4416
Open Access | Times Cited: 80

Carrier-Free Immunotherapeutic Nano-Booster with Dual Synergistic Effects Based on Glutaminase Inhibition Combined with Photodynamic Therapy
Ziyi Mai, Jing Zhong, Jiasi Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 2, pp. 1583-1596
Closed Access | Times Cited: 69

Nanocatalysts for modulating antitumor immunity: fabrication, mechanisms and applications
Xianbo Wu, Yuqing Li, Mei Wen, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 5, pp. 2643-2692
Closed Access | Times Cited: 33

New-generation advanced PROTACs as potential therapeutic agents in cancer therapy
Chao Wang, Yujing Zhang, Wujun Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 27

Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 24

Development of Polymethine Dyes for NIR‐II Fluorescence Imaging and Therapy
Xin Chen, Jieyan Li, Shubham Roy, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 16
Closed Access | Times Cited: 23

Tumor microenvironment responsive nanozymes for multimodal imaging of tumors
Heng Wang, Wenrui Ouyang, Hongxing Liu
Nano TransMed (2024) Vol. 3, pp. 100032-100032
Open Access | Times Cited: 20

Emerging nanomedicines of paclitaxel for cancer treatment
Qin Chen, Shu Xu, Shuo Liu, et al.
Journal of Controlled Release (2022) Vol. 342, pp. 280-294
Closed Access | Times Cited: 63

RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy
Ying Hao, Yuwen Chen, Xinlong He, et al.
Biomaterials (2022) Vol. 293, pp. 121975-121975
Closed Access | Times Cited: 57

Open-Source and Reduced-Expenditure Nanosystem with ROS Self-Amplification and Glutathione Depletion for Simultaneous Augmented Chemodynamic/Photodynamic Therapy
Miaomiao Chen, Shuju Zhao, Jialong Zhu, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 18, pp. 20682-20692
Closed Access | Times Cited: 43

Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy
Weixin Zhou, Yujie Jia, Yani Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2346-2346
Open Access | Times Cited: 43

Microenvironment-responsive nanocarriers for targeted bone disease therapy
Mengmeng Li, Biao Yu, Sicheng Wang, et al.
Nano Today (2023) Vol. 50, pp. 101838-101838
Closed Access | Times Cited: 40

Tumor Therapy Strategies Based on Microenvironment‐Specific Responsive Nanomaterials
Zhaocong Zhang, Chengwen Ding, Tiedong Sun, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 20
Closed Access | Times Cited: 39

Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy
Qiaolin Liu, Yuliang Zhao, Huige Zhou, et al.
Regenerative Biomaterials (2023) Vol. 10
Open Access | Times Cited: 37

Tumor microenvironment-triggered intratumoral in-situ biosynthesis of inorganic nanomaterials for precise tumor diagnostics
Xueni Zhang, Qing Zhao, Jianjun Yang, et al.
Coordination Chemistry Reviews (2023) Vol. 484, pp. 215115-215115
Closed Access | Times Cited: 36

Research Progress on Stimulus-Responsive Polymer Nanocarriers for Cancer Treatment
Shicui Luo, Zhuo Lv, Qiuqiong Yang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1928-1928
Open Access | Times Cited: 23

Enhanced ferroptosis therapy with a “nano-destructor” by disrupting intracellular redox and iron homeostasis
Ting Song, Geng Yang, Hanxi Zhang, et al.
Nano Today (2023) Vol. 51, pp. 101896-101896
Closed Access | Times Cited: 22

Metal–Organic Framework Nanocomposites in Conquering Hypoxia for Tumor Therapy
Shizhao Zhou, Jia Fan, Yingying Wei, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 17
Closed Access | Times Cited: 13

Page 1 - Next Page

Scroll to top